Navigation Links
New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
Date:9/19/2007

PARSIPPANY, N.J., Sept. 19 /PRNewswire/ -- Over 20 new speakers will grace the faculty of the "Pharma & Biotech Competitive Intelligence & Business Analysis" conference in two weeks in New Jersey. The conference is the gold standard for pharmaceutical CI, Business Analysis, and Market Forecasting executives; 200 from the top 25 companies will gather on October 1-2 to attend the meeting. Competition has never been fiercer to launch successful products and monitor competitor moves in crowded therapeutic classes. This year's show brings together an unprecedented gathering of speakers and attendees from around the industry.

Among the many new speakers the audience will have opportunity to hear from are:

-- Bill Sammon

Senior Director of Strategy Information Analysis

Pfizer

-- David Stefanoni

Director, Business Intelligence; Business Excellent, Analytics &

Planning

Sanofi-Aventis

-- David Kamenir

Associate Director, Strategic Brand & Competitor Insights

Novo Nordisk

-- Ian Malcolm

Vice President Strategic Marketing

Exelixis

-- Susanne Laningham

Director Business Analysis & Information

Amgen

-- Thomas Han

Director, Strategic Marketing

Biovail

-- J J Owen

Associate Director, Scientific & Competitor Analysis

Millennium

-- Joshua Owolabi

Assistant Director, Discovery & Assessment Group

TAP Pharmaceuticals

-- Renee Pierson

Director

Ortho McNeil Pharmaceutical

The conference and exhibition will take place in Parsippany, NJ and is the only annual conference featuring 90% pharmaceutical company speakers for just the life sciences industry, reports Mark Alexay of Apaporis, the organizer. 35 pharmaceutical company speakers are featured this year; the attendee list is posted at http://www.pharmabiotechci.com.

The speaking faculty includes a pharmaceutical industry "Who's Who" list of CI professionals from top companies including Alcon Laboratories, Amgen, Aspreva, Bayer HealthCare, Bayer Schering Pharma, Biovail, Boehringer Ingelheim, Centocor, Cyberonics, Cyclacel, Daiichi Medical Research, Eisai, Exelixis, Genentech, Genzyme, Merck, Millennium, Novo Nordisk, Onconova Therapeutics, Organon International, Ortho McNeil Pharmaceutical, Pfizer, Sanofi-Aventis, Shire Laboratories, Supernus Pharmaceuticals, TAP, Wyeth, ZymoGenetics.

Contact the organizers for information or about the exhibition -- Amy Yueh at ayueh@pharmabiotechci.com / 212.228.7974 or Mark Alexay at 201.452.4023.


'/>"/>
SOURCE Apaporis
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. In competitive biotech world, Wisconsin cant afford to fall behind
2. Modernizing the tax code can make Wisconsin tech businesses more competitive
3. Is Googles cafeteria a competitive weapon?
4. Wisconsin can shine in the competitive biotech world, even among the giants
5. Wisconsin must produce more science-savvy students to remain competitive
6. Is your competitive edge really a wedge?
7. Schneider Logistics Helps Manufacturers Secure Competitive Advantage
8. Looking to be Competitive? Try Speed Networking
9. Meat-snack maker selects Prescient Applied Intelligence tech package
10. Are you gathering information or intelligence about competitors?
11. Business Intelligence and Process Effectiveness Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017 Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens today announced ... Ms. Duseau succeeds Paul Thomas , the Company,s President and ... the Company,s Board of Directors.  The changes are effective today. ... Directors, effective today. ...
(Date:1/17/2017)... 17, 2017 Research and Markets has ... Diagnostics - Technologies, Markets and Companies" to their offering. ... ... remarkably during the past few years. More than 1,000 companies ... and 342 of these are profiled in the report along ...
(Date:1/17/2017)... , ... January 17, 2017 , ... Pono Ola ... peaceful and healthy lifestyle, announced today the official launch of its much-anticipated Pono Board: ... mind. , In development for over a year, the patented Pono Board ...
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, Inc. ... it has initiated a global Phase 2b induction ... peptide that targets alpha4beta7 integrin. The aim of ... to evaluate the safety/tolerability and efficacy of PTG-100 ... moderate to severe active disease. ...
Breaking Biology Technology:
(Date:1/12/2017)... 2017  Trovagene, Inc. (NASDAQ: TROV ), ... announced that it has signed agreements with seven strategic ... Middle East for commercialization of ... first wave of international distribution agreements for Trovagene,s CLIA ... The initial partners will introduce Trovagene,s liquid ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, ... studies in healthy volunteers of a novel calcium ... treat acute pancreatitis. Acute pancreatitis, ... a mild disorder, but can be very serious.  In ... and sepsis, where extended hospital stays, time in ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
Breaking Biology News(10 mins):